B-Type Natriuretic Peptide and its Molecular Precursor in Myocardial Infarction Complicated by Cardiogenic Shock

Journal of Cardiac Failure

Volumn 13, Issue 3, 2007, Pages 184-188

  Hejmdal, Anders ^a   Boesgaard, Søren ^a   Lindholm, Matias G ^a   Goetze, Jens Peter ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

BNP; Cardiogenic shock; Myocardial infarction; Natriuretic peptide; proBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CARDIOGENIC SHOCK; CLINICAL ARTICLE; ENDOCRINE FUNCTION; FEMALE; GEL FILTRATION CHROMATOGRAPHY; HEART FAILURE; HEART INFARCTION; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN PROCESSING; RADIOIMMUNOASSAY;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PROTEIN PRECURSORS; SHOCK, CARDIOGENIC;

EID: 34247124051     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2006.11.011     Document Type: Article

References (21)

1. Cowie M.R., Jourdain P., Maisel A., Dahlstrom U., Follath F., Isnard R., et al. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 24 (2003) 1710-1718
2. de Lemos J.A., McGuire D.K., and Drazner M.H. B-type natriuretic peptide in cardiovascular disease. Lancet 362 (2003) 316-322
3. Pfister R., Scholz M., Wielckens K., Erdmann E., and Schneider C.A. Use of NT-proBNP in routine testing and comparison to BNP. Eur J Heart Fail 6 (2004) 289-293
4. Hobbs F.D., Davis R.C., Roalfe A.K., Hare R., and Davies M.K. Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations. Heart 90 (2004) 866-870
5. Costello-Boerrigter L.C., Boerrigter G., Redfield M.M., Rodeheffer R.J., Urban L.H., Mahoney D.W., et al. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol 47 (2006) 345-353
6. Maisel A. The coming of age of natriuretic peptides: the emperor does have clothes!. J Am Coll Cardiol 47 (2006) 61-64
7. Lindholm M.G., Aldershvile J., Sundgreen C., Jorgensen E., Saunamaki K., and Boesgaard S. Effect of early revascularisation in cardiogenic shock complicating acute myocardial infarction. A single center experience. Eur J Heart Fail 5 (2003) 73-79
8. Potapov E.V., Hennig F., Wagner F.D., Volk H.D., Sodian R., Hausmann H., et al. Natriuretic peptides and E-selectin as predictors of acute deterioration in patients with inotrope-dependent heart failure. Eur J Cardiothorac Surg 27 (2005) 899-905
9. Verges B., Zeller M., Desgres J., Dentan G., Laurent Y., Janin-Manificat L., et al. High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock. Eur Heart J 26 (2005) 1734-1741
10. Goetze J.P. Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited. Clin Chem 50 (2004) 1503-1510
11. Goetze J.P., Kastrup J., Pedersen F., and Rehfeld J.F. Quantification of pro-B-type natriuretic peptide and its products in human plasma by use of an analysis independent of precursor processing. Clin Chem 48 (2002) 1035-1042
12. Rehfeld J.F., and Goetze J.P. The posttranslational phase of gene expression: new possibilities in molecular diagnosis. Curr Mol Med 3 (2003) 25-38
13. Brandt I., Lambeir A.M., Ketelslegers J.M., Vanderheyden M., Scharpe S., and De Meester I. Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form. Clin Chem 52 (2006) 82-87
14. Hawkridge A.M., Heublein D.M., Bergen III H.R., Cataliotti A., Burnett Jr. J.C., and Muddiman D.C. Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure. Proc Natl Acad Sci U S A 102 (2005) 17442-17447
15. Yandle T.G., Richards A.M., Gilbert A., Fisher S., Holmes S., and Espiner E.A. Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. J Clin Endocrinol Metab 76 (1993) 832-838
16. Schellenberger U., O'Rear J., Guzzetta A., Jue R.A., Protter A.A., and Pollitt N.S. The precursor to B-type natriuretic peptide is an O-linked glycoprotein. Arch Biochem Biophys 451 (2006) 160-166
17. Goetze J.P., Kastrup J., and Rehfeld J.F. The paradox of increased natriuretic hormones in congestive heart failure patients: does the endocrine heart also fail in heart failure?. Eur Heart J 24 (2003) 1471-1472
18. Babaev A., Frederick P.D., Pasta D.J., Every N., Sichrovsky T., and Hochman J.S. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 294 (2005) 448-454
19. Schou M., Dalsgaard M.K., Clemmesen O., Dawson E.A., Yoshiga C.C., Nielsen H.B., et al. Kidneys extract BNP and NT-proBNP in healthy young men. J Appl Physiol 99 (2005) 1676-1680
20. Goetze J.P., Jensen G., Moller S., Bendtsen F., Rehfeld J.F., and Henriksen J.H. BNP and N-terminal proBNP are both extracted in the normal kidney. Eur J Clin Invest 36 (2006) 8-15
21. Anwaruddin S., Lloyd-Jones D.M., Baggish A., Chen A., Krauser D., Tung R., et al. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol 47 (2006) 91-97